Toxic epidermal necrolysis: current evidence, practical management and future directions.
about
Review of Toxic Epidermal NecrolysisCytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsToxic epidermal necrolysis following treatment of pseudotumour cerebri: a case reportAmniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactionsStevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year studyParaneoplastic pemphigus in a burn intensive care unit: case report and review of the literature.Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.Vesicobullous disorders of female genitalia.Toxic epidermal necrolysis (TEN) Lyell's syndrome.Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.Idiosyncratic adverse reactions to antiepileptic drugs.Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management.Toxic epidermal necrolysis induced by lansoprazole.Drug-hypersensitivity syndrome: diagnosis and treatment.Lyell's Syndrome and Antimalarials: A Case Report and Clinical Review.Emergency dermatopathology.Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.Skin manifestations of drug allergy.Educational case series: Mechanisms of drug allergy.Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.Staphylococcal scalded skin syndrome in neonates: an 8-year retrospective study in a single institution.Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.Blessing or curse? Proteomics in granzyme research.The first reported case of ureteral perforation in a patient with severe toxic epidermal necrolysis syndrome.Corticosteroids in Stevens-Johnson Syndrome/toxic epidermal necrolysis: current evidence and implications for future research.Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Microbiological findings and antibacterial therapy in Stevens-Johnson syndrome/toxic epidermal necrolysis patients from a Swedish Burn Center.Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.Update on the management of antibiotic allergyNine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature.Stage IV cutaneous acute graft-versus-host disease. Clinical and histological study of 15 cases.Ceftriaxone-induced toxic epidermal necrolysis mimicking burn injury: a case report.HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
P2860
Q28074097-BBAE59B8-A657-4458-980F-669D4582B5F6Q28395744-74583C5F-ED40-4035-A565-A19DBC46957CQ33587297-84340962-9B77-40CD-AB38-23EC6A67F9C6Q33786399-7CFA8D6F-F45D-47C5-8BDF-9A5AC1E230E0Q33788588-E620AAD9-D9D8-4415-B366-616AB7DD833BQ33844415-10B7A730-1D14-4096-8A94-E2BFAD4B76FBQ34192104-59A3B42C-B357-4027-85EC-732431B3C722Q35004399-F1B8C398-3D57-4971-899E-4D65F5642B8FQ35686521-3294382B-BF36-46DF-BECC-A7746438BFFEQ35832481-266E199D-9622-4B73-AA19-7CBC2D6055BCQ35868969-45DCF321-8C16-4244-9978-6776CDFE1089Q35890244-45522559-B396-4731-9D3C-07BE4D770248Q36374575-CA0E0A5C-1827-4598-BAE1-7047C1D3897FQ36711702-7EE4B478-7F0B-4C08-9BD4-2CAA9C4655F7Q36770454-2B90FE63-8AF9-44CB-BDF7-0A7A92D4A981Q36884071-7078E8F7-F013-4E11-9D91-42484B84A11BQ36977799-CD469079-2289-45BE-B06B-1E8D89BD5D14Q37577984-D282FCEE-7C24-4EF9-A2E9-65A0F31AADC4Q37671321-79432DCA-17CF-4633-B45E-22BD73680E09Q37756378-EE6CAD5D-66F0-49FE-B8AD-3EB8C691EBA5Q37825557-2AB51712-06F8-463D-828E-49F44F88B04EQ37853599-41EBC5C2-F574-4393-8716-04E632DB3BE8Q37863710-FF669D80-9BA3-4319-9CBE-83220343B78CQ37885432-D3441904-DB66-4A9A-AB94-4D62C08607B9Q37894017-AF954BDB-091C-474D-86A0-F56DC454E22EQ38096015-8B991124-D6B8-4029-A07E-18935C947844Q38118508-E9E23C50-0026-4169-A8EC-385943A2CCBEQ38200060-0E8FFACA-80CC-4CD0-9FB7-C2C33D133F90Q38216219-EDBA4B88-A296-4FAC-8D9B-5B83D346F8EEQ38269208-C13306A8-88BB-4B38-9DCC-07BDC429F1CDQ38766822-F6F82BC6-1A50-48AB-9EE6-1FA45446E903Q39027584-F1EFD775-9B70-426B-865C-3713E09A39E5Q39604704-374FD362-DB49-47F8-879C-DCAA871FEA38Q39830842-F7C12FBD-8628-4BA9-8B5F-070764EC96C1Q40589933-0E46E05F-908F-45CE-B878-E9F0BADBB280Q42281124-B75FD6DC-DACD-467C-9456-439AD7EE78A6Q42455364-60D691E2-1ABF-455F-A25E-B2C6D65EBA32Q42940789-85B2C295-A62B-454A-9FDE-B9BB4ECF442AQ46238859-B3C437C5-AC64-4E79-8633-44C32C859CB0Q51867191-2B6E570F-5D4C-4AE6-93A6-5DDC9594E007
P2860
Toxic epidermal necrolysis: current evidence, practical management and future directions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@ast
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@en
type
label
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@ast
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@en
prefLabel
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@ast
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@en
P2093
P2860
P1476
Toxic epidermal necrolysis: current evidence, practical management and future directions.
@en
P2093
Hutchinson PE
Mortimer NJ
Sladden MJ
P2860
P304
P356
10.1111/J.1365-2133.2005.06721.X
P407
P577
2005-08-01T00:00:00Z